Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WQ0R
|
|||
| Drug Name |
Anti-T-lymphocyte immune globulin
|
|||
| Indication | Graft-versus-host disease [ICD-11: 4B24; ICD-9: 279.5] | Phase 3 | [1] | |
| Company |
Neovii Biotech Munich, Germany
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.